Scopus BioPharma Inc.

OTCPK:SCPS Stock Report

Market Cap: US$12.6k

Scopus BioPharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure7.6yrs

Recent management updates

Recent updates

Do Institutions Own Scopus BioPharma Inc. (NASDAQ:SCPS) Shares?

Mar 16
Do Institutions Own Scopus BioPharma Inc. (NASDAQ:SCPS) Shares?

CEO

Scopus BioPharma has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Ira Greenspan
Senior Advisor & Director8.1yrsUS$200.00kno data
Robert Gibson
Vice Chairman8.1yrsUS$200.00kno data
David Buckel
Independent Director4.4yrsUS$55.00kno data
Aharon Schwartz
Member of Scientific Advisory Boardno datano datano data
Raphael Hofstein
Independent Director3yrsUS$41.33kno data
David Weild
Independent Director4.4yrsUS$55.00kno data
George Kunos
Member of Scientific Advisory Board7.6yrsno datano data
Joshua Lamstein
Chairman8.1yrsUS$231.08kno data
Joseph Tam
Member of Scientific Advisory Board6.6yrsno datano data
Robert Spiera
Member of Scientific Advisory Board7.6yrsno datano data
Yair Levy
Member of Scientific Advisory Board7.6yrsno datano data
Hua Yu
Member of Scientific Advisory Boardno datano datano data

7.6yrs

Average Tenure

66yo

Average Age

Experienced Board: SCPS's board of directors are considered experienced (7.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 09:02
End of Day Share Price 2025/05/14 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Scopus BioPharma Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aydin HuseynovBenchmark Company